$GTHP ultra low float $0.0049 My MVP OTC contes
Post# of 98042
Posted On: 07/15/2016 7:14:46 PM
$GTHP ultra low float $0.0049
My MVP OTC contest entry
And I own it.
Website
$262,000 of sales in 1Q 2016, a 106% increase from 2015
Record number of disposable LuViva® Cervical Guides shipped in Q1
Nearing 100 LuVivas shipped worldwide
Continued growth in the Middle East and Southeast Asia
Sale of 5 LuViva devices approved by Nairobi County, Kenya, for screening
Expanded distribution in Latin America
Negotiations with potential Chinese and Indian partners progressing[
Shares Outstanding: 4.67M
Float: 2.57M
% Held by Insiders: 9.49%
% Held by Institutions: N/A
Shares Short (as of Aug 12, 2003): 0.00
Short Ratio (as of Aug 12, 2003): 0.00
Short % of Float (as of Aug 12, 2003): N/A
Shares Short (prior month): 4.13K
Headlines
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company primarily develops LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. It is also developing a non-invasive esophageal cancer detection product using its biophotonic technology platform. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.
My MVP OTC contest entry
And I own it.
Website
$262,000 of sales in 1Q 2016, a 106% increase from 2015
Record number of disposable LuViva® Cervical Guides shipped in Q1
Nearing 100 LuVivas shipped worldwide
Continued growth in the Middle East and Southeast Asia
Sale of 5 LuViva devices approved by Nairobi County, Kenya, for screening
Expanded distribution in Latin America
Negotiations with potential Chinese and Indian partners progressing[
Shares Outstanding: 4.67M
Float: 2.57M
% Held by Insiders: 9.49%
% Held by Institutions: N/A
Shares Short (as of Aug 12, 2003): 0.00
Short Ratio (as of Aug 12, 2003): 0.00
Short % of Float (as of Aug 12, 2003): N/A
Shares Short (prior month): 4.13K
Headlines
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company primarily develops LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. It is also developing a non-invasive esophageal cancer detection product using its biophotonic technology platform. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.
(0)
(0)Scroll down for more posts ▼